SCHEMBL22492099

SCHEMBL22492099

O=C(O)[C@H]1CCC(F)(F)C[C@@H]1c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNQ3 O43525 5/20 0.53
KCNQ2 O43526 5/20 0.53
KCNQ4 P56696 3/20 0.53
KCNQ5 Q9NR82 3/20 0.53
MCL1 Q07820 1/20 0.42
AKR1C3 P42330 1/20 0.40
AKR1C1 Q04828 1/20 0.40
FFAR1 O14842 1/20 0.40
POLB P06746 1/20 0.39
TSHR P16473 1/20 0.39
HDAC4 P56524 1/20 0.39
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
CHRM2 P08172 3/20 0.37
CHRM1 P11229 3/20 0.37
CHRM3 P20309 3/20 0.37
MAPK1 P28482 1/20 0.37
ACE P12821 1/20 0.36
SLC9A1 P19634 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22492105 1.00 KCNQ3 (0.53) KCNQ3KCNQ2KCNQ4KCNQ5MCL1
SCHEMBL22492104 1.00 KCNQ3 (0.53) KCNQ3KCNQ2KCNQ4KCNQ5MCL1
SCHEMBL21611474 0.87 KCNQ3 (0.64) KCNQ3KCNQ2KCNQ4KCNQ5MCL1
SCHEMBL21611473 0.87 KCNQ3 (0.64) KCNQ3KCNQ2KCNQ4KCNQ5MCL1
SCHEMBL21611476 0.87 KCNQ3 (0.64) KCNQ3KCNQ2KCNQ4KCNQ5MCL1
SCHEMBL22492042 0.86 KCNQ3 (0.41) KCNQ3KCNQ2KCNQ4KCNQ5MCL1
SCHEMBL22492037 0.86 KCNQ3 (0.41) KCNQ3KCNQ2KCNQ4KCNQ5MCL1
SCHEMBL22492040 0.86 KCNQ3 (0.41) KCNQ3KCNQ2KCNQ4KCNQ5MCL1
SCHEMBL23646315 0.84 MCL1 (0.46) KCNQ3KCNQ2KCNQ4KCNQ5MCL1
SCHEMBL23646453 0.81 KCNQ3 (0.40) KCNQ3KCNQ2KCNQ4KCNQ5MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11332472-B2 Substituted piperidines as inhibitors of ubiquitin specific protease 7 LES LABORATOIRES SERVIER (FR) 2022-05-17 US disclosed
US-20210221785-A1 AMINO-PYRIMIDONYL DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM VERNALIS (R&D) LTD (GB) 2021-07-22 US disclosed
US-20200407363-A1 NEW PIPERIDINYL DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 LES LABORATOIRES SERVIER (FR) 2020-12-31 US disclosed
EP-3717482-A1 NEW PIPERIDINYL DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 Les Laboratoires Servier SAS (FR) 2020-10-07 EP disclosed
CN-111542524-A Novel piperidinyl derivatives as inhibitors of ubiquitin-specific protease 7 法国施维雅药厂 2020-08-14 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11332472-B2 Substituted piperidines as inhibitors of ubiquitin specific protease 7 USP7, PSMA7, PSMB7 KCNQ3 4231/4885KCNQ2 3921/4885KCNQ4 4466/4885
US-20210221785-A1 AMINO-PYRIMIDONYL DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DHFR, QDPR, DPYD KCNQ3 914/4885KCNQ2 766/4885KCNQ4 1112/4885
US-20200407363-A1 NEW PIPERIDINYL DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 PSMB7, PSMA7, USP7 KCNQ3 4378/4885KCNQ2 3943/4885KCNQ4 4511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.